FIELD: medicine.
SUBSTANCE: invention refers to medicine, and concerns pharmaceutical compositions for parenteral drip introduction for treating time zone change syndrome.
EFFECT: well-selected, balanced qualitative and quantitative composition provides a dosage form suitable for treating desynchronization, the therapeutic effect of which is manifested rather quickly for 0,5–2 hours.
1 cl, 3 ex
Authors
Dates
2019-12-18—Published
2019-10-15—Filed